Loading...
Market
Sanofi's R&D efficiency increased significantly by mid-2025?
4
Resolution / Starting Odds
Yes • 50%
No • 50%
Sanofi's financial and R&D reports
Story
Sanofi Partners with OpenAI, Formation Bio to Accelerate Drug Development
May 21, 2024, 06:14 AM
French drugmaker Sanofi announced on Tuesday that it is collaborating with artificial intelligence company OpenAI and Formation Bio to boost its drug development projects through the use of Artificial Intelligence. This partnership aims to accelerate the drug development process, leveraging advanced AI technologies to enhance research and development efficiency. Sanofi Chief Digital Officer Emmanuel Frenehard elaborated on the details of this collaboration.
View original story
Similar markets
Increase significantly • 25%
Increase slightly • 25%
Remain stable • 25%
Decrease • 25%
